STAT+: Hospitals and pharma are both on the hook to help fund infrastructure deal
WASHINGTON — Both hospitals and drug makers are on the hook to help pay for…
Author: STAT
STAT+: Lawmakers ask Defense Department about using a controversial maneuver to lower drug prices
Three years ago, Congress directed the Department of Defense to take steps to lower the…
Efficacy of Pfizer/BioNTech Covid vaccine slips to 84% after six months, data show
The efficacy of the Covid-19 vaccine developed by Pfizer and BioNTech fell from 96% to…
STAT+: Deep Genomics raises $180 million to automate drug discovery
Brendan Frey, the founder and chief executive of Deep Genomics, thinks the wrong people are…
Opinion: Pharmacoequity: a new goal for ending disparities in U.S. health care
The Covid-19 pandemic has brought to the public’s attention alarming racial disparities in health. According…
STAT+: Pharmalittle: Biogen yanks Alzheimer’s paper from JAMA over edits; Pfizer sees $33.5 billion in Covid-19 vax sales
Top of the morning to you, and a fine one, it is. Delicious cool breezes…
.jpg)
Opinion: Listen: A journalist on what the Vietnam War taught us about addiction
In this week’s episode of the “First Opinion Podcast,” science journalist and author Lauren Aguirre…
Opinion: Cancer killed my mother, brother, and sisters. As the longest-living member of my family, I was determined to understand why
July 10 was a bittersweet and emotional day for me this year, one I had…
STAT+: For the first time ever, Lander’s White House science office will have an entire wing dedicated to health
WASHINGTON — Eric Lander, the renowned genomics researcher, has kept a low profile in his…
‘There is a real cost’: As Covid shows, barring bedside visitors from ICU deprives patients of the best care
For Teresa Ciappa, home was other people — and for the people in her life,…
STAT+: Animal rights activists get new ammunition in their battle over a controversial rodent test
In what animal rights activists see as a significant development, a pair of U.K. health…
Opinion: A solution to the murky legal status of vaccine mandates: rewrite vaccine EUAs
It has been quite a week for vaccine mandates in the United States. The Department…
CDC to recommend masks indoors even for some vaccinated against Covid-19
Federal health officials will recommend Tuesday that even people who’ve had their Covid-19 shots wear…
.jpg)
Investigating Epic’s AI, an unhealthy digital divide, & a new day for interoperability
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
What happened to the FDA’s toughest regulator?
You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…
STAT+: Pharmalittle: Pharma lobbies Congress on global tax proposal; the FDA doc at center of Aduhelm controversy
Rise and shine, everyone, another busy day is on the way. We can tell because…
STAT+: STAT+ Conversations: A conversation on scrutiny facing Epic’s health care algorithms
Editor’s note: A livestream of the conversation will be embedded below at 1 p.m. ET….
STAT+: Purdue says most creditors voted in favor of contentious bankruptcy plan
In an apparent victory for Purdue Pharma, preliminary voting shows most creditors are in favor…
Never too late: Cancer centers push patients to quit smoking
When cancer patients stop smoking, they heal faster, experience fewer side effects from treatment and…
Opinion: On compounding, the FDA marches to the beat of its own biases
The FDA’s approval of the drug Aduhelm as a treatment for Alzheimer’s disease — despite…
Opinion: The first challenge for ARPA-H should be electronic health record migration
Most new, high-profile initiatives start with something splashy. President Biden’s proposed transformative biomedical agency, the…
Biden wants to bolster the pharma supply chain. A major generic plant closing may make that harder
If you think bolstering the pharmaceutical supply chain in the U.S. is a national priority,…
STAT+: How Biogen found a believer: At the FDA, a hard-nosed regulator was won over on controversial Alzheimer’s drug
When the drug maker Biogen pitched its Alzheimer’s treatment to a panel of independent experts…
STAT+: Pharmalittle: A race to develop Covid-19 pills is underway; Russian trolls target Pfizer vaccine
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Opinion: On menthol cigarettes, social justice theory shouldn’t trump science
This year, 45,000 Black Americans will die from tobacco-related illnesses. The same number will likely…
Opinion: 21 states give rare disease patients a seat at the table. The other 29 need to follow suit
A powerful movement is taking shape in the U.S. rare disease community that could transform…
Researchers analyzed 4,063 papers on tools to help guide care. Only 12 were replications
Clinical decision support is one of digital health’s great promises. Faced with a surplus of…
STAT+: Microbiome therapy companies face the fallout of failed Seres trial
A frost may be setting in across the microbiome therapeutics space after another clinical trial…
A new way to visualize the surge in Covid-19 cases in the U.S.
The month of July has seen Covid-19 cases in the United States increase at the…
STAT+: Epic’s AI algorithms, shielded from scrutiny by a corporate firewall, are delivering inaccurate information on seriously ill patients
Several artificial intelligence algorithms developed by Epic Systems, the nation’s largest electronic health record vendor,…
Opinion: A turning point for children: creating an AIDS-free generation
Forty years after the first AIDS cases were reported, the harsh reality is that deep…
STAT+: Pharmalittle: Biogen’s ‘symptom quiz’ for Aduhelm draws fire; most U.S. clinical trials flunk transparency rules
Good morning. Elizabeth Cooney sitting in for Ed Silverman on what from here looks like…
How concerned should we be about breakthrough coronavirus infections? One expert weighs in
In the past week, you may have heard about Olympic athletes who are fully vaccinated…
Opinion: Patient advocacy organizations and FDA drug approval: lessons from Aduhelm
In the wake of last month’s controversial Food and Drug Administration approval of Biogen’s Aduhelm,…
Opinion: Medicine needs to see what disability means, looks like, and feels like — in its ranks and in its patients
Licensers, employers, and others have asked about my status: disabled or not disabled? The first…
Why is Delta such a big deal? And other burning questions about the next phase of the Covid-19 pandemic
The rise of the Delta variant has driven new Covid-19 outbreaks, rattled markets, and reminded…
Listen: Breakthrough infections, the power of lobbying, & pharma’s cinematic villainy
Did we take off our masks too soon? Can Democrats pass a drug pricing bill?…
STAT+: Most clinical trials failed to meet U.S. transparency requirements for recently approved drugs
In the latest look at clinical trial transparency, a new analysis found that only 26%…
U.S. sees first cases of dangerous fungus resistant to all drugs in untreated people
For the first time ever, researchers have reported cases of people carrying or infected with…
When Covid first hit, prostate cancer surgeries fell much more for Black men than white men
Last year’s lockdown during the early days of the coronavirus pandemic erased cancer surgery from…
Alphabet firm DeepMind releases massive database of 3D protein structures
With the advent of cheap genetic sequencing, the world of biology has been flooded with…
STAT+: Pharmalittle: Biogen defends its controversial Alzheimer’s drug; critics pan Pfizer plan for Covid-19 shot production in Africa
Hello, everyone, and how are you today? A shiny sun and delightful breeze are enveloping…
Biogen mounts defense of its Alzheimer’s drug, saying ‘misinformation’ is fueling controversy
Biogen on Thursday mounted a vigorous defense of its controversial Alzheimer’s drug, Aduhelm, with the…
STAT+: Seres Therapeutics’ microbiome therapy for ulcerative colitis falls short in Phase 2 trial
Seres Therapeutics’ highly anticipated clinical trial in ulcerative colitis failed to meet its primary endpoint,…
Opinion: The answer to medical misinformation on social media might be more information
When the surgeon general of the United States speaks, people tend to listen. So Vivek…
Opinion: Proven ways to boost Covid-19 vaccination: mandates plus nudges
The United States is approaching a plateau in vaccination rates at a perilous moment as…
STAT+: Happify to release prescription app to treat depression under loosened FDA rules
Leveraging Food and Drug Administration regulations loosened during the pandemic, Happify Health, which is best…
The baby was gravely ill. Rapid sequencing turned around a diagnosis in 13 hours — and pointed to a treatment
When the boy was brought to the San Diego emergency department one night last October,…
Public health officials have tools to beat back Covid again. Does anyone want to use them?
Before Covid-19 vaccines, public health officials fought off the pandemic with the only tools they…
In the same health system, Black patients are prescribed fewer opioids than white patients
Inequities in health care are pervasive, from access to quality of care, and a new…